PTPPentixapharm Holding AG NPartial data
1.895EUR+0.26%Mkt Cap: 51.05M $P/E:

Pentixapharm Holding AG, a clinical-stage biopharmaceutical company, develops radiopharmaceuticals. The company focuses on developing CXCR4 binding, peptide-based technology, which includes PentixaFor (PT-001), a tracer …

Key Statistics

Company
Market Cap51.05M $
Enterprise Value46.87M $
Revenue (TTM)263.04K $
Gross Profit-7.29M $
Net Income (TTM)-17.95M $
Revenue/Share0.0109 USD
Last Price1.895 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees38
CountryDE
SectorHealthcare
IndustryBiotechnology
ISINDE000A40AEG0
Valuation
P/E (Trailing)
P/E (Forward)-2.90
PEG
EV/EBITDA-2.45
EV/Revenue178.19
P/S3.96
P/B1.67
EPS (TTM)-0.58
EPS (Forward)-0.66
52W Range
1.30025% of range3.700
52W High3.700 EUR
52W Low1.300 EUR
Profitability
Gross Margin-7207.53%
Oper. Margin-23880.00%
EBITDA Margin0.00%
Profit Margin-17753.76%
ROE-47.08%
ROA-39.44%
Growth
Revenue Growth-91.20%
Earnings Growth
Cash Flow & Leverage
Operating CF-19.54M $
CapEx (TTM)679.35K $
FCF Margin-4078.62%
FCF Yield-21.02%
Net Debt-3.91M $
Net Debt/EBITDA0.20
Balance Sheet
Debt/Equity
Current Ratio1.55
Quick Ratio1.26
Book Value/Sh1.149 EUR
Cash/Share0.1450 EUR
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 EUR
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)9.265 EUR
Upside (mean)+388.9%
Target Range7.200 EUR11.33 EUR
7.200+388.9% to mean11.33
# Analysts2
Ownership
Shares Out.500.00K
Float18.09M
Insiders30.99%
Institutions6.06%
Technical
SMA 502.077 (-8.8%)
SMA 2001.950 (-2.8%)
Beta
S&P 52W Chg19.97%
Avg Vol (30d)31.00K
Avg Vol (10d)34.45K
Technical Indicators
RSI (14)42.2
MACD-0.0618
MACD Signal-0.0647
MACD Hist.+0.0029
BB Upper2.154 EUR
BB Middle1.966 EUR
BB Lower1.779 EUR
BB Width19.08%
ATR (14)0.1071 EUR
Vol Ratio (20d)0.56x